Order Article Reprints

Caccese M, Simonelli M, Villani V, Rizzato S, Ius T, Pasqualetti F, Russo M, Rudà R, Amoroso R, Bellu L, et al. Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study. Cancers. 2022; 14(10):2425. https://doi.org/10.3390/cancers14102425

Caccese, Mario, Matteo Simonelli, Veronica Villani, Simona Rizzato, Tamara Ius, Francesco Pasqualetti, Marco Russo, Roberta Rudà, Rosina Amoroso, Luisa Bellu, and et al. 2022. "Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study" Cancers 14, no. 10: 2425. https://doi.org/10.3390/cancers14102425

Caccese, M., Simonelli, M., Villani, V., Rizzato, S., Ius, T., Pasqualetti, F., Russo, M., Rudà, R., Amoroso, R., Bellu, L., Bertorelle, R., Cavallin, F., Dipasquale, A., Carosi, M., Pizzolitto, S., Cesselli, D., Persico, P., Casini, B., Fassan, M., ... Lombardi, G. (2022). Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study. Cancers, 14(10), 2425. https://doi.org/10.3390/cancers14102425